Bridge Biotherapeutics, a Korean stock, rose over 20% today, with its market value reaching approximately $36 million

According to BlockBeats, on June 20th, the stock price of Bridge Biotherapeutics, Inc., a South Korean listed biotechnology company, rose 20.59% today, with a market value of KRW 49.218 billion, or approximately USD 36 million. Parataxis Holdings, an investment company that previously focused on the digital asset field, announced that it has signed a final agreement with Bridge Biotherapeutics, Inc., a biotechnology company, to invest 25 billion Korean won and gain control of the company (the "Transaction"). After the transaction is completed, the company plans to change its company name to Parataxi Korea and continue to be listed on KOSDAQ.